Apotheker Neyt
ActiveApotheker Neyt has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €699k and a net result of €178k. Equity is growing by ~37.4% per year across the filed fiscal years. Its solvency ranks better than 67% of 10242 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.6% (low).
Checked score
Score 2025
90
/ 100
Excellent▼ -10 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100=
Solvency97▼-1
Growth78=
Stability100
Bankruptcy probability, 12 months
0.6%
Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €65k at 30 days acceptable
Liquidity ample (current ratio 2.74 against 6.21 in 2024), and 46.3% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
53.7%
Return on assets
13.7%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 27-02-2026, 154 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
154 d early
2024
13 d early
2023
14 d early
2022
12 d early
2021
2 d early
2020
1 d early
2019
21 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
15-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€699k▼ 13.3%
2024 · €806k
2018: €82k
2019: €169k
2020: €214k
2021: €317k
2022: €452k
2023: €610k
2024: €806k
2018 → 2025
Total assets
€1.30M▼ 5.3%
2024 · €1.37M
2018: €888k
2019: €994k
2020: €1.03M
2021: €1.05M
2022: €1.14M
2023: €1.24M
2024: €1.37M
2018 → 2025
Net result
€178k▼ 11.7%
2024 · €201k
2018: €-29k
2019: €89k
2020: €70k
2021: €120k
2022: €142k
2023: €159k
2024: €201k
2018 → 2025
Working capital
€569k▼ 26.9%
2024 · €778k
2018: €95k
2019: €150k
2020: €209k
2021: €279k
2022: €413k
2023: €583k
2024: €778k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€317k-€452k▲ 42.7%€610k▲ 35.0%€806k▲ 32.1%€699k▼ 13.3%
Operating result€156k-€204k▲ 31.0%€217k▲ 6.1%€276k▲ 27.5%€242k▼ 12.6%
Net result€120k-€142k▲ 18.1%€159k▲ 12.1%€201k▲ 26.6%€178k▼ 11.7%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 13% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €1.30M
Fixed assets
€406k▼ 9.0%
Current assets
€895k▼ 3.5%
Equity and liabilities €1.30M
Equity
€699k▼ 13.3%
Debt
€602k▲ 6.1%
The debt ratio rises from 41.3% to 46.3%: debt grows while equity shrinks.
Key figures and ratios
EBITDA
€294k▼
2024 · €328k
Cash flow
€230k▼
2024 · €253k
Solvency
53.7%▼
2024 · 58.7%
Current ratio
2.74▼
2024 · 6.21
Quick ratio
1.93▼
2024 · 4.38
Debt / equity
0.86▲
2024 · 0.70
ROE
25.4%▲
2024 · 25.0%
ROA
13.7%▼
2024 · 14.7%
Interest coverage
63.53▼
2024 · 65.18
Debt
€602k▲
2024 · €567k
Debt ≤ 1 year
€326k▲
2024 · €149k
Debt > 1 year
€275k▼
2024 · €417k
Income taxes
€77k▼
2024 · €88k
Staff costs
€121k▲
2024 · €101k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€1.37M€1.30M▼
Fixed assets21/28€446k€406k▼
Intangible fixed assets21€34k€19k▼
Tangible fixed assets22/27€412k€377k▼
Land and buildings22€398k€368k▼
Plant, machinery and equipment23€14k€10k▼
Furniture and vehicles24€0-
Financial fixed assets28-€9k
Current assets29/58€927k€895k▼
Amounts receivable after more than one year29€50k€50k=
Other amounts receivable291€50k€50k=
Stocks and contracts in progress3€273k€265k▼
Stocks30/36€273k€265k▼
Amounts receivable within one year40/41€105k€118k▲
Trade receivables40€99k€110k▲
Other amounts receivable41€7k€8k▲
Current investments50/53€155k€215k▲
Cash at bank and in hand54/58€340k€240k▼
Deferred charges and accrued income490/1€4k€8k▲
Equity and liabilities
Total equity and liabilities10/49€1.37M€1.30M▼
Equity10/15€806k€699k▼
Contributions10/11€25k€25k=
Reserves13€780k€673k▼
Distributable reserves133€780k€673k▼
Profit (loss) carried forward14€499€702▲
Amounts payable17/49€567k€602k▲
Amounts payable after more than one year17€417k€275k▼
Financial debts170/4€417k€275k▼
Amounts payable within one year42/48€149k€326k▲
Current portion of amounts payable after more than one year42€42k€42k▲
Trade debts44€36k€50k▲
Suppliers440/4€36k€50k▲
Advances received on contracts in progress46€69€0▼
Taxes, remuneration and social security45€65k€37k▼
Taxes450/3€37k€10k▼
Remuneration and social security454/9€28k€28k▼
Other amounts payable47/48€6k€197k▲
Accrued charges and deferred income492/3€581€407▼
Income statement
Code20242025
Remuneration, social security and pensions62€101k€121k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€52k€52k▲
Other operating charges640/8€5k€5k▼
Gross operating margin9900€435k€420k▼
Operating profit (loss)9901€276k€242k▼
Financial income75/76B€18k€18k▼
Recurring financial income75€18k€18k▼
Financial charges65/66B€5k€5k▼
Recurring financial charges65€5k€5k▼
Profit (loss) for the period before taxes9903€289k€255k▼
Income taxes67/77€88k€77k▼
Profit (loss) for the period9904€201k€178k▼
Profit (loss) for the period to be appropriated9905€201k€178k▼
Appropriation of the result
Profit (loss) to be appropriated9906€201k€178k▼
Profit (loss) brought forward from the previous period14P€208€499▲
Transfer from equity791/2-€278k
Transfer to equity691/2€196k€171k▼
To the legal reserve6920€196k-
To other reserves6921€0€171k▲
Profit to be distributed694/7€5k€285k▲
Return on contributions (dividend)694€0€278k▲
Other beneficiaries697€5k€6k▲
Social balance
Average headcount (FTE)90872.22.5▲
The notes to these accounts (25 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
27-02
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
18-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
31-12
Financial
Highest result since 2018net €201k ▲26.6%
Operating result €276k, net result €201k, both a record.
17-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Equity above €500kEq €610k ▲35%
5 profitable years in a row build equity to €610k.
19-07
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
29-07
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Equity above €200kEq €214k ▲26.8%
2 profitable years in a row build equity to €214k.
21-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 21 days late
2019
31-12
Financial
Back to profitnet €89k
Net result €89k after one loss-making year.
31-12
Financial
Equity above €150kEq €169k ▲105%
Equity rises from €82k to €169k.
10-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 71 days late
2018
31-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 31 days late
2017
11-08
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Brugge · 1 establishment unit since 2017
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Geldmuntstraat 328000 BruggeGround area
215 m²
Building footprint
114 m²
Volume, LiDAR
1,414 m³
Parcel 31804D0698/00C000, Flanders · tallest building 15.8 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
Apotheker Neyt
since 20172.272.376.933
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 31804D0698/00C000 | Flanders | 215 m² | 1 · 114 m² | 15.8 m · 4 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Recognitions · licences · registrations
Food safety, FASFC
1 siteBrugge2.272.376.933
Similar companies · same sector, comparable size
APOTHEEK LEFEVER - DE CLOEDT
BE 0421.212.996
Knokke-Heist · Eq €699k
MANAGEMENT CAROLINE VANDECASTEELE
BE 0536.437.813
Leuven · Eq €698k
DE LUCHTHAVEN APOTHEEK
BE 0873.145.696
Zaventem · Eq €699k
DE BIE T.
BE 0832.636.914
Affligem · Eq €700k
G-PAS HOLDING
BE 0882.523.420
Brasschaat · Eq €698k
Of 5,209 companies in sector 47730 we hold annual accounts for 3,851. 3,220 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded20-08-2012
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 13 filingsAddress and cadastre registers
Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.